Replies to post #442753 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

To be specific "outcome measures" would be right as one of those changed in the AVATAR trial and in the P2b/3 trial the same in the form of pretty meaningless Odds Ratio for ADK and to date no baseline to EOT mean.

Those two trials have as a matter of fact not met all their endpoint protocol defined outcome measures.

For the record stating fact can never be bashing, but as I said some will never accept the facts about those two readouts and you of all is on that list too.